Trial · NCT07537257
VEN+IDAC vs IDAC in AML
NCT07537257, Phase 2, Phase 3, Enrolling by invitation, Guangdong Second Provincial General Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. VEN+IDAC vs IDAC in AML. Trials, record NCT07537257. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07537257
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- VEN+IDAC vs IDAC in AML
- NCT number
- NCT07537257
- Status
- Enrolling by invitation
- Phases
- Phase 2, Phase 3
- Enrollment
- 232 participants, estimated
- Lead sponsor
- Guangdong Second Provincial General Hospital
- Conditions
- AML (Acute Myelogenous Leukemia)
- Interventions
- Ventoclax, Cytarabine
- First posted
- 2026-04-17
- Last updated
- 2026-04-17
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Rate of Measurable residual disease (MRD) negative | At the end of cycle 2 (28 days for a cycle) | MRD is monitored using flow cytometric analysis with a positive MRD threshold of 0.1%. |
| Secondary | Cumulative Incidence of Recurrence (CIR) | 2 years | Assess the risk of leukemia recurrence after the consolidation |
| Secondary | Overall survival (OS) | 2 years | OS is calculated from enrollment to death or the last follow-up. |
| Secondary | Disease Free Survival (DFS) | 2 years | It refers to the time from the start of the consolidation to disease recurrence or death from any cause or the last follow-up. |
| Secondary | Aderse events | At the end of cycle 2 (28 days for a cycle) | Side effects of the consolidations including haematological and non-haematological toxicity. |
| Secondary | The rate of being bridged to allogeneic hematopoietic stem cell transplantation | 2 years | To assess how many patients are needed to accept allogeneic hematopoietic stem cell transplantation after the consolidation. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07537257
GET https://conductscience.org/api/trials/v1/NCT07537257/registered